SORVASTA 15 MG TBL FLM 28X1

What is the maximum co-payment for SORVASTA?

If the insurance company contributes, the maximum co-payment is 257,38 Kč. The maximum pharmacy price is 324,79 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but the reimbursement conditions (reporting limit) have not been set.

Does SORVASTA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

67,41 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe SORVASTA?

Prescription is not conditional on a medical specialization.

What is the composition of SORVASTA?

Vápenatá sůl rosuvastatinu (15,62 mg), rosuvastatin (15 mg), neznámá látka s kódem 3755, laktosa, neznámá látka s kódem 17840, koloidní bezvodý oxid křemičitý, magnesium-stearát, neznámá látka s kódem 17627, makrogol 6000, oxid titaničitý, monohydrát laktosy. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to SORVASTA?

The medicine belongs to ATC group C10AA07 – ROSUVASTATIN. Medicines with the same active substance can be found here.

Who manufactures SORVASTA?

Krka, d.d., Novo mesto, Novo mesto (SLO)

Is the medicine in shortage?

The latest report from the manufacturer is from 23. 3. 2021. Production was terminated with effect from 23. 3. 2021. The manufacturer lists medicines with the following code as a potential substitute: